This Week at FDA: Leqembi fully approved, Senators at odds over PAHPA, and more

This Week at FDAThis Week at FDAAPIsBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsDiagnostics/IVDsMedical DevicesNorth AmericaNutritional/Natural HealthOTCOtherPharmaceuticalsRegulatory Intelligence/Policy